New GI guidelines add two treatments for chronic constipation

New clinical guidance from leading medical bodies has expanded treatment options for chronic idiopathic constipation, adding two widely available therapies to the list of evidence-based approaches.

The updated recommendations, published by the American Gastroenterological Association and the American College of Gastroenterology, outline 10 validated treatment strategies for chronic idiopathic constipation (CIC) in adults, a long-term condition with no clearly identified cause.

Among the key updates are the inclusion of magnesium oxide and senna—two treatments that have been newly recognised in the guideline’s evidence-based framework.

Chronic idiopathic constipation affects an estimated 8% to 12% of people in the United States and is characterised by infrequent, difficult, or incomplete bowel movements.

According to experts involved in the guideline development, the recommendations were based on a review of randomized, placebo-controlled clinical trials using the GRADE methodology, which assesses the quality and certainty of scientific evidence.

Magnesium oxide, a widely available over-the-counter supplement, is now listed as a supported treatment option. 

Medical experts explain that it works by drawing water into the intestines, helping to soften stool and promote bowel movement.

Clinicians typically recommend starting at lower doses, around 400–500 milligrams per day, with a maximum suggested limit of 1,500 milligrams daily depending on patient response.

Senna, a plant-derived stimulant laxative, has also been included in the updated guidance. It works by stimulating contractions in the colon to help move stool through the digestive tract.

While effective, specialists note it may cause cramping at higher doses and is generally recommended for intermittent use rather than daily consumption.

The guidelines also reaffirm several existing treatments, including osmotic laxatives such as polyethylene glycol, stimulant laxatives like bisacodyl, and newer prescription therapies targeting gut motility and secretion.

Medical experts emphasise that treatment decisions should be individualised, taking into account patient preferences, cost, and accessibility, alongside clinical evidence.

In addition to medication, specialists highlight lifestyle-based approaches that may support symptom relief. 

These include increasing fluid intake, consuming adequate dietary fibre, engaging in regular physical activity, and managing stress levels.

Other supportive strategies such as pelvic floor therapy and abdominal massage are also noted as beneficial for some patients.

Healthcare professionals stress that persistent constipation should not be ignored, as it may sometimes signal underlying conditions such as thyroid disorders, medication side effects, or, in rare cases, more serious gastrointestinal disease.

Doctors recommend seeking medical evaluation if symptoms are new, persistent, or accompanied by warning signs such as blood in the stool, unexplained weight loss, or a family history of colorectal cancer.